Topics
News
CME/CE
Editorial Advisory Board
Partnerships
Botox has long duration of action for Tx of axillary hyperhidrosis
Washington - Intradermal botulinum toxin type A (Botox) for the treatment of primary axillary hyperhidrosis produces a durable effect, with nearly half of patients requiring only one treatment over a one-year period, according to study data released at the annual meeting of the American Academy of Dermatology here.
Related Videos
Related Content
Editorial Advisory Board Insights for Eczema Awareness Month: Raj Chovatiya, MD, PhD
October 1st 2023
Editorial Advisory Board Insights for Eczema Awareness Month: Raj Chovatiya, MD, PhD
October 1st 2023
